ZKB/PUT/DOCMORRIS/70/0.01/06.01.25 Stock

ZKB/PUT/DOCMORRIS/70/0.01/06.01.25 Share Price

DOCSPZ

CH1281049663

Market Closed - Swiss Exchange 16:20:00 31/05/2024 BST
0.14 ^CHF	+7.69%

3 months	+16.67%
Current year	-22.22%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart DOCMORRIS AG

Chart ZKB/PUT/DOCMORRIS/70/0.01/06.01.25

Latest news about DOCMORRIS AG

DocMorris : AGM Minutes 2024	05-30	PU
Warburg: Several mid-caps attractive takeover targets - and Mercedes-Benz	05-27	DP
DOCMORRIS : Warburg Research reiterates its Buy rating	05-27	ZD
Global markets live: Anglo American, Nvidia, Apple, Amazon, Tesla, Walt Disney...	05-23

More news

Quotes 5-day view

Date	Price	Change
31/05/24	0.14	+7.69%
29/05/24	0.13	-.--%
28/05/24	0.13	-18.75%

Delayed Quote Swiss Exchange

Last update May 31, 2024 at 04:20 pm

More quotes

Static data

Product type	Warrants
Buy / Sell	PUT
Underlying	DOCMORRIS AG
Issuer	ZKB
	DOCSPZ
ISIN	CH1281049663
Date issued	08/12/2023
Strike	70 CHF
Maturity	06/01/2025 (219 Days)
Parity	100 : 1
Emission price	0.17 CHF
Emission volume	N/A
Settlement	les deux
Currency	CHF

Technical Indicators

Highest since issue	0.21 CHF
Lowest since issue	0.085 CHF
Delta	-0.43x
Omega	1.973
Premium	17.47x
Gearing	4.64x
Moneyness	1.041
Difference Strike	2.75 CHF
Difference Strike %	+3.93%
Spread	0.01 CHF
Spread %	6.67%
Theoretical value	0.1450
Implied Volatility	64.18 %
Total Loss Probability	37.82 %
Intrinsic value	0.0275
Present value	0.1175
Break even	55.50 CHF
Theta	-0x
Vega	0x
Rho	-0x

Company Profile

Zur Rose Group AG is a Switzerland-based company engaged in the drug distribution sector. The Company focuses on the wholesale trade of medicines, as well as operation of a mail-order pharmacy. The Company's activities are divided into two business segments: Zur Rose and DocMorris. The Zur Rose division includes wholesale business and provides drugs to medical doctors, health insurance companies, hospitals and healthcare companies, among others. The DocMorris division manages the mail-order business for drug retail. The Company operates in Switzerland, Germany and the Netherlands through a number of subsidiaries, such as Zur Rose Suisse AG, Zur Rose Pharma GmbH, BlueCare AG, DocMorris NV, Eurapon Pharmahandel GmbH and Vitalsana BV.

Sector

More about the company

Ratings for DocMorris AG

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

Consensus: DocMorris AG

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

67.25 CHF

Average target price

99.24 CHF

Spread / Average Target

+47.57%

Consensus